Cargando…

Primary angiosarcoma of breast: A case report and literature review

INTRODUCTION AND IMPORTANCE: Primary angiosarcoma of breast (PAB) is a rare and aggressive malignancy with limited published literature. This article aims to disclose the diagnosis and treatment of this case, review previous case reports, and provide clinical experience to breast surgeons. CASE PRES...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min, Yin, Ke, Chen, Lin, Shang, Xingchen, Yang, Qing, Tian, Xingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173155/
https://www.ncbi.nlm.nih.gov/pubmed/37120900
http://dx.doi.org/10.1016/j.ijscr.2023.108219
Descripción
Sumario:INTRODUCTION AND IMPORTANCE: Primary angiosarcoma of breast (PAB) is a rare and aggressive malignancy with limited published literature. This article aims to disclose the diagnosis and treatment of this case, review previous case reports, and provide clinical experience to breast surgeons. CASE PRESENTATION: A 36-year-old Asian female presented with a diffuse mass growing rapidly in her left breast. The ultrasonography (USG) suspected granulomatous mastitis. The core needle biopsy (CNB) confirmed the diagnosis of breast angiosarcoma (AS). She underwent mastectomy without axillary lymph node dissection (ALND) followed by adjuvant chemotherapy. About 11 months after mastectomy, the patient had bone metastasis. CLINICAL DISCUSSION: PAB is a rare vascular neoplasia, characterized by aggressive patterns, poor prognosis, and high malignant potential. It is difficult to diagnose or differentiate only by clinical or imaging examination. Biopsy and immunohistochemical staining are the most reliable method. Mastectomy is the most common treatment. CONCLUSION: PAB is a rare and malignant cancer. We should pay attention to the diffuse progressive masses in the breast of young female, and perform MRI and biopsy if necessary. Mastectomy is the only treatment known that has proven to benefit these patients. There are no evidence-based guidelines regarding treatment.